SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -100.0% | 3,200 | -17.9% | 0.00% | – |
| Q3 2022 | $6,000 | – | 3,898 | +34.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 2,900 | -63.8% | 0.00% | – |
| Q1 2022 | $1,000 | -92.9% | 8,000 | +536.9% | 0.00% | -100.0% |
| Q4 2018 | $14,000 | -33.3% | 1,256 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $21,000 | +23.5% | 1,256 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $17,000 | -26.1% | 1,256 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $23,000 | -62.9% | 1,256 | -90.1% | 0.00% | -33.3% |
| Q4 2017 | $62,000 | -47.9% | 12,700 | -47.7% | 0.00% | -25.0% |
| Q3 2017 | $119,000 | +52.6% | 24,300 | -19.0% | 0.00% | +33.3% |
| Q2 2017 | $78,000 | +457.1% | 30,000 | -21.1% | 0.00% | – |
| Q1 2017 | $14,000 | -82.9% | 38,000 | -35.6% | 0.00% | -100.0% |
| Q4 2016 | $82,000 | +2.5% | 58,993 | -64.1% | 0.00% | 0.0% |
| Q3 2016 | $80,000 | -73.8% | 164,193 | +32.5% | 0.00% | -80.0% |
| Q2 2016 | $305,000 | +43.2% | 123,923 | -38.6% | 0.02% | +7.1% |
| Q1 2016 | $213,000 | -68.5% | 201,816 | +11.6% | 0.01% | -63.2% |
| Q4 2015 | $677,000 | – | 180,916 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |